Cargando…

Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study

OBJECTIVE: To investigate the clinical efficacy and adverse events (AEs) of apatinib salvage treatment for diffuse malignant peritoneal mesothelioma (DMPM) that has failed to respond to the recommended treatments. METHODS: 27 patients with refractory DMPM were treated with apatinib at our center fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhi-Ran, Su, Yan-Dong, Ma, Ru, Wu, He-Liang, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283831/ https://www.ncbi.nlm.nih.gov/pubmed/35847956 http://dx.doi.org/10.3389/fonc.2022.811800

Ejemplares similares

Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
por: Yang, Zhi-Ran, et al.
Publicado: (2020)

Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases
por: Gros, Louis, et al.
Publicado: (2021)

Apatinib for salvage treatment of advanced malignant pleural mesothelioma: A case report
por: Du, Zedong, et al.
Publicado: (2018)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Diffuse malignant peritoneal mesothelioma: A review
por: Sun, Luanbiao, et al.
Publicado: (2023)

NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine
por: Wu, He-liang, et al.
Publicado: (2022)

Diffuse malignant peritoneal mesothelioma mimicking ovarian cancer.
por: Houssaini, Zaynab Iraqi, et al.
Publicado: (2021)

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
por: Kusamura, Shigeki, et al.
Publicado: (2023)

Surgical Treatment of Malignant Peritoneal Mesothelioma: Past, Present, and Future
por: Alexander, H. Richard
Publicado: (2009)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Diffuse malignant peritoneal mesothelioma presenting as small bowel obstruction
por: Tagliaferri, Ariana R., et al.
Publicado: (2023)

A Rare Case of Biphasic Malignant Peritoneal Mesothelioma with Refractory Ascites
por: Komaki, Tomo, et al.
Publicado: (2017)

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma
por: Napolitano, Andrea
Publicado: (2019)

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma
por: Belfiore, Antonino, et al.
Publicado: (2019)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Preclinical Models of Malignant Mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2020)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Efficacy and Response Biomarkers of Apatinib in the Treatment of Malignancies in China: A Review
por: Tian, Zhichao, et al.
Publicado: (2021)

Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience
por: Xie, Lu, et al.
Publicado: (2021)

Kinetics of Host Cell Recruitment During Dissemination of Diffuse Malignant Peritoneal Mesothelioma
por: Miselis, Nathan R., et al.
Publicado: (2010)

Primary diffuse malignant peritoneal mesothelioma in a striped skunk (Mephitis mephitis)
por: KIM, Su-Min, et al.
Publicado: (2015)

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
por: Sciarrillo, Rocco, et al.
Publicado: (2018)

Diffuse Peritoneal Malignant Mesothelioma Presenting with Abnormal Uterine Bleeding: Case Report
por: Rizzuto, Ivana, et al.
Publicado: (2022)

Molecular Pathways in Peritoneal Mesothelioma: A Minireview of New Insights
por: Fortarezza, Francesco, et al.
Publicado: (2022)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
por: Pezzuto, Federica, et al.
Publicado: (2021)

Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer
por: Su, Meng, et al.
Publicado: (2019)

Initial or salvage treatment with apatinib shows promise against radioiodine-refractory differentiated thyroid carcinoma
por: Qiu, Xian, et al.
Publicado: (2022)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

Primary malignant peritoneal mesothelioma mimicking tuberculous peritonitis: A case report
por: Lin, Li-Cheng, et al.
Publicado: (2022)

Treatment of Patients with Malignant Peritoneal Mesothelioma
por: Li, Claire Y., et al.
Publicado: (2022)

Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma
por: Yang, Zhi-Ran, et al.
Publicado: (2021)

Challenging Diagnostic Process for a Malignant Peritoneal Mesothelioma Patient With Ascites and Pleural Effusion: A Case Report and Review of the Literature
por: Zeng, Xiaofeng, et al.
Publicado: (2022)

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases
por: Wu, He-liang, et al.
Publicado: (2022)

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
por: Alakus, Hakan, et al.
Publicado: (2015)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation
por: Yang, Yongguang, et al.
Publicado: (2021)

Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis
por: Mitsuka, Yuusuke, et al.
Publicado: (2010)

Malignant peritoneal mesothelioma. Is there a new treatment?
por: Rasul, Kakil Ibrahim, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8mmtp1clng1ui0gitnbt70atq0